Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Royaltama Mulia Kontraktorindo Tbk. (RMKO) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Royaltama Mulia Kontraktorindo Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Royaltama Mulia Kontraktorindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Royaltama Mulia Kontraktorindo Tbk. trades at Rp280 (market cap 450.94B, 3.31M 24h volume). The key difference: Royaltama Mulia Kontraktorindo Tbk. is the larger of the two by market cap, and Royaltama Mulia Kontraktorindo Tbk. is more actively traded (3.31M versus 41.7K). Which is the better fit depends on your goals.

DGNSRMKO
Market Cap
316.25B450.94B
Volume
41.7K3.31M
Lot
41733.11K
Turnover
9.66M938.29M
Average Price
231.65283.41
Value
9.66M938.29M
Indicative Equilibrium Price
230280
Indicative Equilibrium Volume
2.4K131

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
RMKO
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Royaltama Mulia Kontraktorindo Tbk.

PT Royaltama Mulia Kontraktorindo Tbk was established based on Notarial Deed No. 2 datedDecember 18, 2017 of Muhammad Firmansyah, S.H., M.Kn., a public notary in Tangerang. The Company started its commercial operations in 2018.

Read more on RMKO